Blog - Page 584 of 5641 - QualityStocks

FridaySep 29, 2023 1:06 pm

QualityStocksNewsBreaks – Knightscope, Inc. (NASDAQ: KSCP) Announced Two Additional K5 ASR Orders Added to Expansion Contract

Knightscope (NASDAQ: KSCP), a leading developer of autonomous security robots (“ASRs”) and blue light emergency communication systems, is continuing to add to its client roster. This time the company has inked deals with its first-ever ASR clients in Louisiana: two casinos, one located in Shreveport and the other in Bossier City. According to the announcement, the two K5 ASR contracts have been executed as part of a larger agreement Knightscope received earlier this month. The contracts call for the two casinos to each receive a K5 robot. These two new ASRs bring the total robots under the contract to five, with…

FridaySep 29, 2023 11:33 am

QualityStocksNewsBreaks — LNG Energy Group Corp. (TSX.V: LNGE) (TSX.V: LNGE.WT) (OTCQB: LNGNF) (FRA: 6MH) Files Mind Cure Financial Docs; Announces Options and DSU Grants

LNG Energy Group (TSX.V: LNGE) (TSX.V: LNGE.WT) (OTCQB: LNGNF) (FRA: 6MH), a company focused on the acquisition and development of natural-gas production and exploration assets in Latin America, has filed the consolidated annual financial statements and management discussion and analysis for Mind Cure Health Inc., its predecessor entity; the financial statements were filed for the fiscal year ended May 31, 2023. As part of the announcement, the company also noted that CFO Angel Roa and COO Nicolas Ziperovich have agreed to settle management and consulting fees owed to them in common capital shares of the company. Specifically, Roa will receive 269,280 common…

FridaySep 29, 2023 11:15 am

PaxMedica Inc. (NASDAQ: PXMD) Releases Compelling Video: Progress Report on ASD and Hope for the Future

Autism Spectrum Disorder (“ASD”) has seen a staggering fourfold increase in the United States over the past two decades PaxMedica proudly stands as the sole publicly traded U.S. company singularly dedicated to addressing the challenges posed by Autism Our pioneering lead product, PAX-101, has shown significant promise in alleviating core Autism symptoms during early trials In 2024, we're poised to submit a New Drug Application (“NDA”) for PAX-101 to treat Human African Trypanosomiasis (“HAT”), a rare disease also known as African Sleeping Sickness, as part of the Neglected Rare Tropical Disease Program With NDA approval, we anticipate the potential to…

FridaySep 29, 2023 10:30 am

GEMXX Corp. (GEMZ) Plans 300% YoY Expansion in Gemstone and Jewelry Production to Meet Growing Demand

GEMXX is a mine-to-market enterprise that specializes in the production and distribution of gemstones, like Ammolite, and jewelry on a global scale Ammolite is a rare gemstone that exhibits a unique iridescence and is only found in southern Alberta, Canada The company recently announced that demand for its Ammolite in jewelry designs by Kenneth Bradley is growing exponentially GEMXX plans to expand gemstone and jewelry production by 300% year over year in response to growing demand Its shopping channel division is preparing to supply $5.5 million worth of Ammolite gemstones and jewelry over the next 12 months Although officially recognized…

FridaySep 29, 2023 9:45 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Steadily Advancing its DehydraTECH(TM) Technology, Having Demonstrated its Potential Across Multiple Areas of Application

Lexaria’s patented DehydraTECH(TM)-processed CBD has shown its ability to lower blood pressure in patients over multiple weeks This technology has also shown positive impacts in obese diabetic-conditioned animals from its DIAB-A22-1 pre-clinical study The NIC-H22-1 human nicotine study also demonstrated a statistically significant difference to achieve maximum blood saturation These results have demonstrated DehydraTECH’s potential while propping it to take advantage of vastly untapped markets with potential for growth in the coming years Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, is steadily advancing its patented DehydraTECH(TM) technology for its growing range of applications, which include oral…

FridaySep 29, 2023 9:00 am

Unveiling the Neuroprotective Power of CNMAu8 A Promising Breakthrough in Neurodegenerative Disease Treatment

by Elaine Mendonça On September 28, 2023, Clene Inc. (NASDAQ: CLNN) made an exciting announcement regarding their groundbreaking research on the investigational drug CNM-Au8. In a scientific paper published in the esteemed journal Small, Clene Inc. revealed the catalytic mechanism of action behind the therapeutic properties of CNM-Au8. The study showcased the remarkable neuroprotective abilities of CNM-Au8, attributing its success to its unique catalytic activity. When exposed to toxins that typically lead to neuronal death, CNM-Au8 treatment exhibited a remarkable ability to promote cell survival and preserve the intricate network of neurites. To truly understand the underlying mechanisms responsible for CNM-Au8’s neuroprotective function,…

ThursdaySep 28, 2023 1:08 pm

QualityStocksNewsBreaks – Appia Rare Earths & Uranium Corp. (CSE: API) (OTCQX: APAAF) (FSE: A0I0) Completes First Phase of Drilling Initiatives Across PCH Iconic Clay Project

Appia (CSE: API) (OTCQX: APAAF) (FSE: A0I0, A0I0.F, A0I0.MU, A0I0.BE) today provided an update on the progress of its ongoing drilling program to outline the extent of the mineralized zone at Target IV on its PCH Iconic Clay Project in Brazil. The company has processed and sent 2,255 samples for analysis, from both the Reverse Circulation (“RC”) and Auger drill programs to date and expects to release results in the near future. “Appia’s RC extensive drilling program at Target IV has reached a total of 147 holes, and we have now completed the first phase of the multi-phase drilling initiatives…

ThursdaySep 28, 2023 12:43 pm

QualityStocksNewsBreaks — Mullen Automotive Inc. (NASDAQ: MULN) Announces Class 3 EVs Begin Shipping

Mullen Automotive (NASDAQ: MULN), an emerging electric vehicle (“EV”) manufacturer, has delivered the first 10 class 3 EV Cab Chassis Truck to Randy Marion Automotive Group; the vehicles are invoiced at $630,000. According to the announcement, these first 10 vehicles are the initial shipment of an order for 1,000 class 3 vehicles, an order worth $63 million; the order was placed in May 2023. The company anticipates delivering an additional 150 EVs to Randy Marion by the end of 2023, with the remainder of the 1,000-vehicle order slated for delivery throughout 2024. Calling the delivery a “watershed moment” for the…

ThursdaySep 28, 2023 12:23 pm

QualityStocksNewsBreaks – Canada Nickel Company Inc. (TSX.V: CNC) (OTCQX: CNIKF) Announces Successful Pilot Results Confirming Value of Novel IPT Carbonation Process

Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF) today announced that it has successfully completed its carbon storage pilot plant, demonstrating the value of its novel carbon storage process, In-Process Tailings (“IPT”) Carbonation. According to the update, the company processed more than 7 tonnes of tailings and confirmed the engineering design parameters for IPT Carbonation for incorporation in the Integrated Feasibility Study (“IFS”) expected to be released on Oct. 12, 2023. The pilot plant also was utilized to successfully apply the IPT Carbonation process to material from a third party, demonstrating the potential to commercialize the process for other projects. In addition,…

ThursdaySep 28, 2023 11:49 am

QualityStocksNewsBreaks – Clene Inc. (NASDAQ: CLNN) Investigational Drug Focus of Study Published in Peer-Reviewed Journal

Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s disease, and multiple sclerosis, announced the publication of a scientific paper. The paper, which was published in the “Small” journal, describes the catalytic mechanism of action of CLNN’s investigational drug CNM-Au8(R). “Small” is a leading nanotechnology-focused journal focused on the interface of materials from science, chemistry, physics, engineering, medicine and biology. Titled “A Mechanism Underpinning the Bioenergetic Metabolism-Regulating Function of Gold Nanocatalysts,” the article examines the…

Site Search

Company Search